Agoracom Blog Home

Posts Tagged ‘$TSXV’

Monarques Gold $MQR.ca Estimates Pit-Constrained Resource on its Swanson Gold Project $MUX.ca $SII.ca

Posted by AGORACOM-JC at 8:56 AM on Wednesday, June 20th, 2018

Emerging gold producer in Abitibi (CNW Group/Monarques Gold Corporation)

  • The Swanson maiden mineral resource estimate for a combined pit-constrained and underground scenario is as follows:
    • A pit-constrained Indicated resource of 90,319 ounces and Inferred resource of 941 ounces, and an underground Indicated resource of 7,732 ounces and Inferred resource of 5,975 ounces.
  • The advantageous location of the Swanson deposit, some 100 metres from a railway track, provides easy access to the Beacon mill.
  • The Corporation holds a mining lease on the Swanson property, enabling it to put the deposit into production more rapidly.
  • Monarques Gold continues to increase its combined Measured and Indicated resources to more than 3.1 million ounces of gold (see table 3 at the end of press release).

MONTREAL, June 20, 2018 /CNW/ – MONARQUES GOLD CORPORATION (“Monarques”, “Monarques Gold” or the “Corporation”) (TSX-V:MQR) (OTCMKTS:MRQRF) (FRANKFURT:MR7) is pleased to report the results of a mineral resource estimate for its Swanson gold project, 65 kilometres north from its wholly-owned Beacon mill and 12 kilometres northeast of Barraute, Quebec. The CN railway line crosses the property, some 100 metres north of the Swanson deposit. Monarques acquired a 100% interest in the Swanson and McKenzie Break properties from Agnico Eagle Mines Limited (NYSE:AEM, TSX:AEM) (see press release dated December 21, 2017). The resource estimate was prepared by Christine Beausoleil, P.Geo. and Alain Carrier, P.Geo., M.Sc., of InnovExplo Inc., both qualified and independent persons as defined by NI 43-101. The effective date of the estimate is June 15, 2018.

“The great advantage of the Swanson project is that the railway track is directly on the property, which allows easy access to both our mills,” said Jean-Marc Lacoste, President and Chief Executive Officer of Monarques. “Much like for the McKenzie Break project, we are very pleased to have a pit-constrained resource for the Swanson project (see figure), as this could also mean additional feed for the Beacon mill.  In addition, Monarques holds a mining lease on the Swanson property, which could allow us to put the deposit into production more quickly. Our new strategy of targeting pit-constrained resources from our McKenzie Break and Swanson properties, together with the reopening of our Beacon Mill at the end of the year, could be a winning solution for all three projects.”

The 2018 maiden mineral resource estimate was prepared using Leapfrog GEO and GEOVIA GEMS software. Leapfrog was used for 3D modelling of the four mineralized zones while GEMS was used for grade estimation and block modelling. Statistical studies were done using Snowden Supervisor and Microsoft Excel software. The estimate was performed using 3D block modelling with the Ordinary Kriging interpolation method.

The diamond drilling database contains the results of 146 surface and 63 underground drill holes provided by Monarques. Basic univariate statistics were performed on datasets of individual raw gold assays for each zone and for the dilution envelope. The capping (30 g/t Au) was applied on raw assays before compositing at 1.5 m.

The estimate is reported for a potential scenario combining pit-constrained and underground resources at a cut-off grade of 0.8 g/t Au (pit constrained) and 2.7 g/t Au (underground). The cut-off grades were calculated using a gold price of USD1,296/oz, a CAD:USD exchange rate of 1.28 and the following parameters: (a) pit-constrained scenario: mining cost CAD4.94/t, processing cost CAD27.00/t, General and administrative CAD4.00/t, pit slope of 50 degrees used during Whittle optimization; (b) underground scenario: mining cost CAD90.00/t, processing cost CAD27.00/t, General and administrative CAD10.00/t.

The Swanson project mineral resource estimate for a potential scenario combining pit-constrained and underground resources at cut-off grades of 0.8 g/t Au (pit-constrained) and 2.7 g/t Au (underground) is summarized in the following table 1, whereas table 2 shows the sensitivity analysis of the Swanson maiden mineral resource estimate for the pit-constrained scenario.

Table 1 – Swanson Maiden Mineral Resource Estimate for a combined pit-constrained and underground scenario at a cut-off grade of 0.8 g/t Au (in pit) and 2.7 g/t Au (underground)

Indicated Resource

Inferred Resource

Zone

Tonnage

Grade
(g/t Au)

Ounces

Tonnage

Grade
(g/t Au)

Ounces

Pit-constrained  

1,568,000

1.79

90,319

12,000

2.44

941

Underground  

75,000

3.21

7,732

60,000

3.10

5,975

Total

1,643,000

1.86

98,051

72,000

2.99

6,917

 

Notes to the mineral resource table:

•

These mineral resources are not mineral reserves, as they do not have demonstrated economic viability.

•

The 2014 CIM definitions and guidelines for mineral resources have been followed.

•

Results are presented in situ and undiluted and considered to have reasonable prospects for economic extraction.

•

The estimation encompasses four zones with a minimum true thickness of 2.5 m using the grade of the adjacent material when assayed, or a value of zero when not assayed.

•

A high-grade capping of 30 g/t Au (4 g/t Au for the dilution envelope) was applied to assay grades prior to compositing grade for interpolation using an Ordinary Kriging interpolation method, based on 1.5 m composite for block size of 3 m x 3 m x 3 m.

•

Bulk density values were applied on the following lithological basis (g/cm3): I2 = 2.78; I4O, V3, V4 = 2.90, and OVB = 1.5.

•

The number of metric tons was rounded to the nearest thousand and the metal contents are presented in troy ounces (tonne x grade / 31.10348).

•

InnovExplo is not aware of any known environmental, permitting, legal, title-related, taxation, socio-political or marketing issues, or any other relevant issue not reported in this Technical Report that could materially affect the mineral resource estimate.

 

Table 2 – Sensitivity analysis of the Swanson Maiden Mineral Resource Estimate for the pit-constrained scenario

Indicated Resource

Inferred Resource

Cut off

Au (g/t)

Tonnes

Ounces

Cut off

Au (g/t)

Tonnes

Ounces

0.6

1.65

1,798,000

95,499

0.6

2.22

14,000

997

0.7

1.72

1,685,000

93,157

0.7

2.28

13,000

952

0.8

1.79

1,568,000

90,319

0.8

2.44

12,000

941

0.9

1.87

1,453,000

87,173

0.9

2.56

11,000

907

1

1.94

1,338,000

83,651

1

2.66

10,000

856

 

The NI 43-101 technical report will be delivered and filed on SEDAR within the next 45 days.

The technical and scientific content of this press release has been reviewed and approved by Marc-André Lavergne, Eng., the Corporation’s qualified person and by Christine Beausoleil, P.Geo. and Alain Carrier, P.Geo., M.Sc. of InnovExplo Inc., all of whom are qualified persons as defined by NI 43-101.

ABOUT MONARQUES GOLD CORPORATION

Monarques Gold Corporation (TSX.V:MQR) is an emerging gold producer focused on pursuing growth through its large portfolio of high-quality projects in the Abitibi mining camp in Quebec, Canada. The Corporation currently owns close to 300 km² of gold properties (see map), including the Beaufor Mine, the Croinor Gold (see video), Wasamac, McKenzie Break and Swanson advanced projects, and the Camflo and Beacon mills, as well as six promising exploration projects. It also offers custom milling services out of its 1,600 tonne-per-day Camflo mill. Monarques enjoys a strong financial position and has more than 150 skilled employees who oversee its operating, development and exploration activities.

Forward-Looking Statements

The forward-looking statements in this press release involve known and unknown risks, uncertainties and other factors that may cause Monarques’ actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Table 3 – Monarques Gold Measured and Indicated Resources

Tonnes
(metric)

Grade
(g/t Au)

Ounces

Wasamac property1

Measured Resources

3.99 million

2.52

323,300

Indicated Resources

25.87 million

2.72

2,264,500

Total Measured & Indicated Resources

29.86 million

2.70

2,587,900

Beaufor Mine2

Measured Resources

74,400

6.71

16,100

Indicated Resources

271,700

7.93

69,300

Total Measured & Indicated Resources

346,200

7.67

85,400

Croinor Gold Mine3

Measured Resources

80,100

8.44

21,700

Indicated Resources

724,500

9.20

214,300

Total Measured & Indicated Resources

804,600

9.12

236,000

Swanson property4

Indicated Resources

1,643,000

1.86

98,051

McKenzie Break property5

Pit Constrained

Indicated Resources

939,860

1.59

48,133

Underground

Indicated Resources

281,739

5.90

53,448

Simkar Gold property6

Measured Resources

33,570

4.71

5,079

Indicated Resources

208,470

5.66

37,905

Total Measured & Indicated Resources

242,040

5.52

42,984

TOTAL

Measured & Indicated Resources

3,151,916

1 Source: Technical Report on the Wasamac Project, Rouyn-Noranda, Québec, Canada, Tudorel Ciuculescu, M.Sc.,

P.Geo., October 25, 2017, Roscoe Postle Associates Inc.

2 Source: NI-43-101 Technical Report on the Mineral Resource and Mineral Reserve Estimates of the Beaufor Mine

as at September 30, 2017, Val-d’Or, Québec, Canada, Carl Pelletier, P. Geo. and Laurent Roy, Eng.

3  Source: Monarques prefeasibility study (January 19, 2018) and resource estimate (January 8, 2016)

4 Source: NI 43‐101 Technical Report on the Swanson Project, June 15, 2018, Christine Beausoleil, P.Geo. and

Alain Carrier, P.Geo., M.Sc. of InnovExplo Inc.

5 Source: NI 43‐101 Technical Report on the McKenzie Break Project, April 17, 2018, Alain-Jean Beauregard,

P.Geo., and Daniel Gaudreault, Eng., of Geologica Groupe-Conseil Inc., and Christian D’Amours, P.Geo., of
GeoPointCom Inc.

6 Source: MRB et Associés (January 2015)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/monarques-gold-estimates-pit-constrained-resource-on-its-swanson-gold-project-300669001.html

SOURCE Monarques Gold Corporation

View original content with multimedia: http://www.newswire.ca/en/releases/archive/June2018/20/c8059.html

Jean-Marc Lacoste, President and Chief Executive Officer, 1-888-994-4465, [email protected], www.monarquesgold.com; Elisabeth Tremblay, Senior Geologist – Communications Specialist, 1-888-994-4465, [email protected], www.monarquesgold.comCopyright CNW Group 2018

How Big Will the Battery Boom Get? Try $548 Billion, BNEF Says #Lithium $NAM.ca

Posted by AGORACOM-JC at 11:34 AM on Tuesday, June 19th, 2018
  • Batteries will attract $548 billion in investments by 2050 as costs fall and homes and businesses push to use more clean energy
  • One of the conclusions of the New Energy Outlook released Tuesday by analysts at Bloomberg New Energy Finance
  • Batteries will become increasingly viable on the grid as demand for electric cars spurs manufacturing of lithium-ion systems, driving down prices
(Bloomberg) — Batteries will attract $548 billion in investments by 2050 as costs fall and homes and businesses push to use more clean energy.

That’s one of the conclusions of the New Energy Outlook released Tuesday by analysts at Bloomberg New Energy Finance. Batteries will become increasingly viable on the grid as demand for electric cars spurs manufacturing of lithium-ion systems, driving down prices.

Batteries will allow more solar and wind to meet demand — even when the sun isn’t shining or wind isn’t blowing, helping end the era of fossil fuel dominance on the grid by mid-century, BNEF said. Battery prices are expected to fall to $70 a kilowatt-hour by 2030, down 67 percent from today, according to the report. BNEF expects 1,288 gigawatts of new batteries to be commissioned by 2050.

“It’s a matter of ‘when and how’ and not ‘if’ wind, solar and battery technologies will disrupt electricity delivery all over the world,” Seb Henbest, lead author the report, said in an interview.

©2018 Bloomberg L.P.

Source: https://www.bloombergquint.com/business/2018/06/19/how-big-will-the-battery-boom-get-try-548-billion-bnef-says

5 Industries Likely to Be Disrupted by #Blockchain $SX $SX.ca $SXOOF $IDK.ca #Blockstation

Posted by AGORACOM-JC at 10:49 AM on Tuesday, June 19th, 2018
  • Bitcoin, has the unique ability to change the world
  • Blockchain is an open, distributed database of transactions
  • think of it as an unhackable digital accounting book – and it has endless possibilities for making everything we do more secure, efficient and quick

Cynthia Johnson

Guest Writer
Co-founder and CEO of Bell + Ivy, marketer, speaker and author

In 2018, everyone seems to have a Bitcoin story. Remember that guy you read about who became a millionaire overnight? But the Bitcoin story is much more significant than this. Blockchain, the technology underlying and enabling Bitcoin, has the unique ability to change the world. Blockchain is an open, distributed database of transactions — think of it as an unhackable digital accounting book – and it has endless possibilities for making everything we do more secure, efficient and quick.

1. Energy grids.

What if you could replace America’s ancient, crumbling energy grids with automatically executing, efficient, green and affordable energy systems that could withstand the ravages of hurricanes and other climate change-triggered extreme weather events? Blockchain offers a path to that future. Already, in Brooklyn and in neighborhoods around the country, innovators are experimenting with blockchain-enabled smart grids that allow anyone with a solar panel to buy and sell energy, executed using automated “smart contracts” based on data gathered through smart meters installed in homes. All transactions all verified and secured by blockchain, and no middleman utility company is needed — cutting prices and increasing efficiency.

2. Real estate.

Anyone who’s ever purchased a home knows how many steps — and how much of a headache — that process entails. But blockchain offers the potential for doing the whole thing online, securely, and all at once. Sellers could securely transfer over the title and deed, while buyers would send money via cryptocurrency. Blockchain would also provide a way to send property records to the appropriate government agencies. I asked Rawad Rifai, cofounder of Taurus0x, exactly how blockchain applications impact real estate, and he responded, “Blockchain’s applications in real estate speak to the heart of the technology, its unparalleled and revolutionary potential to conduct instantaneous and completely secure transactions,” said Rifai. “There’s no reason this could not be expanded to retail, entertainment, tourism or any of our day-to-day transactions.”

Related: How Blockchain Will Help Small Businesses Challenge Even the Largest Rivals

3. Healthcare.

Blockchain could create a future in which all our health data — doctor visit records, prescriptions, emergency room visits, shots, X-rays and insurance data — is secured and can be easily shared from doctor to doctor. Nearly everyone changes doctors throughout their lifetime. Imagine having a seamless network of secured records that would ensure that your information travels with you, from birth to end of life.

This system could also save your life. Emergency room doctors could be authorized to access your information about allergies, blood type, and even genetic information, to make informed decisions about your care if you were incapacitated and unable to communicate. This system could also be revolutionary in improving health outcomes in developing countries that do not currently have a centralized or digitized health record database. Earlier this year, five healthcare groups started a pilot program surrounding blockchain and its uses in healthcare.

4. Transportation.

Blockchain could create the potential for the Internet of Things–enabled smart cities. Street signs, traffic lights, cars and other moving and static objects would be embedded with sensors, which would collect and send data to a system that would reroute buses, trams, emergency vehicles and other municipal vehicles to find the quickest routes and avoid traffic. The end result? Less congestion, faster commutes and lower carbon emissions. Blockchain-secured sensor data could also help drivers find open parking spots or charging terminals, pay traffic tickets, and report car crashes or maintenance issues.

Related: 12 Startups Utilizing Blockchain Technology in New Ways

5. Education.

As demand for MOOCs and distance education grows, we need a better system to verify graduates’ educational records. Blockchain could essentially act as a notary, ensuring that people can’t forge diplomas and fool prospective employers. Transcripts, diplomas and certificates could all be secured and stored by blockchain and could be easily sent out to employers and other academic institutions. This would help boost the credentials and reputation of nontraditional educational organizations, and help employers ensure they are hiring the right person for the job.

Many industries will feel the positive impact of blockchain. Some will move faster than others, but many industries will eventually need blockchain. The future is wide open, and the opportunities are endless. The most difficult part about blockchain won’t be growth; it will be human adaptation and the ability to hire great tech talent for these new companies.

Source: https://www.entrepreneur.com/article/314548

Marijuana Company of America $MCOA Launches New CBD-Infused Cosmetic Product hempSMART(TM) Face $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:34 AM on Tuesday, June 19th, 2018

15233 mcoa

  • Announced that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART™ Face
  • Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant

Escondido, California–(June 19, 2018) – Marijuana Company of America, Inc. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART Face.

Each bottle of hempSMART Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant. The newly developed hempSMART topical is a nourishing facial moisturizer that combines CBD oil with a unique blend of ayurvedic herbs and botanicals that is designed to refresh, replenish, and restore your skin cells on your face.

The innovative new formula is rich in Omega 3, 6, 7 and 9, along with naturally occurring ceramides and contains synergistic ingredients such as Organic Aloe, Sabi Inchi Oil, Argan Kernel Oil, Macademia Seed Oil, Rose Hip Seed Oil, Pomegranate Seed Oil, Tulsi, Turmeric Oil, Frankinsense, Ashwaganda, Sweet Potato Root Extract, Coconut Oil, and Sea Buckthorn Oil.

MCOA’s CEO, Donald Steinberg, commented, “Our team is excited to announce the expansion of the hempSMART brand into the world of cosmetic products. HempSMART will continue to build upon our already established and unique formulations to provide our customers and affiliates with the tools needed to succeed in the wellness industry.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tetra Bio-Pharma $TBP.ca Adds a New Leader for its Commercial Operations $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:19 AM on Tuesday, June 19th, 2018

Logo tetrabiopharma rgb web

  • Announced that Mr. Richard Giguere has been hired as Executive Vice-President, Commercial Operations
  • He will be responsible for the commercial sales and operations of Tetra Natural Health and Tetra Veterinary Health

Tetra Natural Health and Tetra Veterinary Health

ORLEANS, Ontario, June 19, 2018 – Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Mr. Richard Giguere has been hired as Executive Vice-President, Commercial Operations. He will be responsible for the commercial sales and operations of Tetra Natural Health and Tetra Veterinary Health.

Richard has more than 20 years’ experience in sales and marketing in the pharmaceutical industry from coast to coast. During his career, he has held various business development, management and negotiation positions and launched several new products on the Canadian market. He has worked for various pharmaceutical companies in sectors such as generics, branded products and medical devices. He has also worked with OTC, natural products and original medications. Richard is recognized for his deep ethical sense, respect of others and talent for developing long-term business relationships through flexibility and efficiency. In the past 10 years, he was also a board member at the companies for which he worked.

“We’re very proud to add Richard Giguere to our senior management team. His vast experience in the sales and marketing of OTC, natural health products and original medications in the pharmaceutical industry across Canada will help drive the execution of our corporate strategy for our Tetra Natural Health and Tetra Veterinary Health divisions,” says Guy Chamberland, Interim Chief Executive Officer of Tetra Bio-Pharma.

Richard Giguere’s arrival is perfectly aligned with Tetra Bio-Pharma’s decision to restructure its corporation by commercial markets. While Tetra Bio-Pharma will be dedicated to pharmaceutical development and commercialization of cannabinoid-based prescription drugs and treatments, Tetra Natural Health will develop and sell cannabinoid-based OTC (self-care) products to leverage the post-legalization market and Tetra Veterinary Health will focus on commercialization of cannabinoid-based products for the pet product market.

“I am honored to be able to play an active role in growing both the Tetra Natural Health and Tetra Veterinary Health divisions,” says Richard Giguere, EVP, Commercial Operations. “Tetra has a sound business model, and there are significant opportunities for us to grow our two commercial divisions. I am committed to making the best business and commercial decisions to accelerate the development of these huge potential markets for our cannabinoid-based products.”

As a result of this senior management change, Anne-Sophie Courtois left the corporation thereby terminating her role as Vice President, Marketing and Communications.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
More information at: www.tetrabiopharma.com

For further information, please contact Tetra Bio-Pharma Inc.
Guy Chamberland, Interim Chief Executive Officer
[email protected]

For investors information, please contact:
[email protected]
(438) 504-5784

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514 840 7990 M: 1 514 232 1556

#Digital Ad Spend Reaches an All-Time High of $88 Billion in 2017, With #Mobile Upswing Unabated, Accounting for 57% of Revenue – $GOOD.ca

Posted by AGORACOM-JC at 2:24 PM on Monday, June 18th, 2018
  • Total U.S. digital ad spend reached a record-setting $88 billion last year
  • Represents a 21 percent uptick over the previous year at $72.5 billion, and marks the first time in this report that digital ad revenues have overtaken television (broadcast and cable combined)

Mobile Advertising Hits Landmark $49.9 Billion, While Digital Video Climbs to a Record $11.9 Billion, According to 2017 IAB Internet Advertising Revenue Report

NEW YORK, NY (May 10, 2018) —Total U.S. digital ad spend reached a record-setting $88 billion last year, according to the latest IAB Internet Advertising Revenue Report, released today by the Interactive Advertising Bureau (IAB), and prepared by PwC US.  This represents a 21 percent uptick over the previous year at $72.5 billion, and marks the first time in this report that digital ad revenues have overtaken television (broadcast and cable combined).

Mobile built on its momentum from 2016, when it first took more than half of total revenues—claiming an even bigger slice of the pie in 2017 at 57 percent. Spend on mobile rose from $36.6 billion in 2016 to $49.9 billion in 2017, marking a 36 percent increase year-over-year.

Other highlights from the report include:

  • Digital video hit a record $11.9 billion in 2017, a 33 percent year-over-year increase from $8.9 billion in 2016
  • On mobile devices, video revenue surged by 54 percent to $6.2 billion, representing the first time that mobile video revenues have surpassed desktop video
  • Social media advertising commanded $22.2 billion last year, rising 36 percent over $16.3 billion in 2016
  • Search revenues reached nearly $40.6 billion in 2017, up 18 percent from $34.6 billion in 2016
  • Banner advertising is up 23 percent to $27.5 billion, 67 percent of which is derived from mobile banners.
  • Digital audio, measured for the second time in a full-year report, is up 39 percent to $1.6 billion from $1.1 billion in 2016

“Consumers are increasingly spending a tremendous amount of time with interactive screens and content – from mobile to desktop and audio to OTT – and brands are in lockstep with a growing commitment to digital ad buys,” said Randall Rothenberg, CEO, IAB. “Mobile captured more than half of the total digital ad spend last year and we can easily expect that share to continue to climb. Video also saw significant growth. That is no surprise—especially after seeing buyers clamoring to get into last week’s NewFronts presentations in New York.”

“Smartphones and tablets have become indispensable tools in the hands of consumers, from the moment they wake up to right before they go to sleep,” said Anna Bager, Executive Vice President, Industry Initiatives, IAB. “A double digit uptick in spend on mobile video is testament to both the pull of mobile and consumer’s never-ending demand for sight, sound, and motion—even while on-the-go. In addition, brands are embracing digital audio at a fast clip, recognizing the power of this burgeoning medium.”

“Digital advertising revenues have been steadily rising for several years and buyers continue to increase their investment,” said David Silverman, Partner, PwC US. “From mobile to video, consumers are constantly turning to digital, whether for information, entertainment, shopping, sharing, or more.”

IAB Full Year Report- Comparison of 2017 and 2016 Data (in millions)

 

Revenue (Ad Forms) Full Year 2016 Full Year 2017
% $ % $
Search (Mobile and Desktop) 47.7% $34,575 46.2% $40,630
Banner  (Mobile and Desktop) 30.7% $22,288 31.2% $27,491
      Sponsorships 1.0% $722 0.9% $824
      Rich Media 2.8% $2,011 2.9% $2,509
      Ad banners / display ads 27.0% $19,554 27.4% $24,158
Digital Video Commercials  (Mobile and Desktop) 12.3% $8,926 13.5% $11,863
Other  (Mobile and Desktop) 9.3% $6,732 9.1% $8,023
      Classifieds and Directories 4.2% $3,018 3.8% $3,354
      Lead Generation 3.4% $2,497 3.4% $2,953
      Audio 1.6% $1,130 1.8% $1,574
      Other (Mobile Other) 0.1% $86 0.2% $142
Total 100% $72,521 100% $88,007

 

Revenue (Desktop v Mobile) Full Year 2016 Full Year 2017
% $ % $
Desktop 49.5% $35,881 43.3% $38,105
Mobile 50.5% $36,641 56.7% $49,902
Total 100% $72,521 100% $88,007

 

Revenue (Pricing Models) Full Year 2016 Full Year 2017
% $ % $
Search (Mobile and Desktop) 34.6% $25,085 33.9% $29,794
Banner  (Mobile and Desktop) 64.0% $46,432 62.3% $54,813
Hybrid 1.4% $1,004 3.9% $3,400
Total 100% $72,521 100% $88,007

The following chart highlights quarterly ad revenue since IAB began measuring it in 1996; dollar figures are rounded.

IAB sponsors the IAB Internet Advertising Revenue Report, which is conducted independently by the New Media Group of PwC. The Q4 2017 revenue is estimated based upon a representative sample of the overall survey respondents. The results are considered a reasonable measurement of interactive advertising revenues because the data is compiled directly from information supplied by companies selling advertising on the internet. The survey includes data concerning online advertising revenues from web sites, commercial online services, free email providers, and all other companies selling online advertising.

The full report is issued twice yearly for full and half-year data, and top-line quarterly estimates are issued for the first and third quarters. PwC does not audit the information and provides no opinion or other form of assurance with respect to the information. Past reports are available at www.iab.com/adrevenuereport.

About PwC US
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 158 countries with more than 236,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

©2018 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

About IAB
The Interactive Advertising Bureau (IAB) empowers the media and marketing industries to thrive in the digital economy. Its membership is comprised of more than 650 leading media and technology companies that are responsible for selling, delivering, and optimizing digital advertising or marketing campaigns. The trade group fields critical research on interactive advertising, while also educating brands, agencies, and the wider business community on the importance of digital marketing. In affiliation with the IAB Tech Lab, it develops technical standards and best practices. IAB and the IAB Education Foundation are committed to professional development and elevating the knowledge, skills, expertise, and diversity of the workforce across the industry. Through the work of its public policy office in Washington, D.C., IAB advocates for its members and promotes the value of the interactive advertising industry to legislators and policymakers. Founded in 1996, the IAB is headquartered in New York City and has a San Francisco office.

IAB Media Contact 
Laura Goldberg
347.683.1859
[email protected]

PwC Media Contact
Carey Bodenheimer
213.392.9684
[email protected]

Source: https://www.iab.com/news/digital-ad-spend-reaches-all-time-high-88-billion-2017-mobile-upswing-unabated-accounting-57-revenue/

Tetra Bio-Pharma $TBP.ca Takes on #Fentanyl in Head to Head Trial for the Treatment of Breakthrough Pain $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 10:18 AM on Monday, June 18th, 2018

Logo tetrabiopharma rgb web

  • Announced that Santé Cannabis, the independently credentialed research organization they work with has finalized the clinical study protocol evaluation of PPP001,
  • Will be the first time that cannabis is being compared to fentanyl in a clinical trial

First Clinical Study to Assess Cannabis as an Alternative to Fentanyl

ORLEANS, Ontario, June 18, 2018 — Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Santé Cannabis, the independently credentialed research organization they work with has finalized the clinical study protocol evaluation of PPP001, which will be the first time that cannabis is being compared to fentanyl in a clinical trial. The study protocol has received approval from the Independent Ethics Board (IRB Services) and was recently submitted for review to Health Canada. PPP001 will investigate cannabis as an alternative to fentanyl in the management of breakthrough pain.  Santé Cannabis is a Quebec-based medical clinic specialized in clinical research and cannabis – based therapies.

Health Canada approved clinical trials completed by Tetra Bio-Pharma in 2017 and 2018 have led to a significantly improved understanding of the safety, pharmacokinetics and pharmacodynamics of PPP001 in the treatment of pain and suffering.  The development of clinical research protocols to investigate the use of cannabis as an alternative to fentanyl followed Tetra’s meeting with the Therapeutic Products Directorate (TPD), Health Canada in early 2018. As a prescription drug, PPP001 will be eligible for insurance coverage.

The trial is designed to assess the time-to-relief in patients suffering from breakthrough pain.  Based on its clinical data, Tetra believes that the pharmacodynamic properties of PPP001 may provide a novel alternative to fentanyl.  In addition, the time-to-maximal plasma concentrations of THC suggests that PPP001 will provide rapid relief to the patient’s suffering.

“Patients suffering from breakthrough pain require fast relief.  Overdosing from fentanyl may occur in patients that exceed the recommended dosage in the hope of obtaining a more rapid relief.  The development of a THC-based alternative would help provide a safer option to these patients and help prevent overdosing on fentanyl,” said Dr. Antonio Vigano, an Attending Physician at the Supportive and Palliative Care Division, McGill University Health Centre, an Associate Professor in the department of oncology, McGill University and the Research Director of Santé Cannabis where he is a Principal Investigator in a Phase 3 clinical trial for pain associated with advanced cancer, in addition to a phase 2 trial for chronic pain. “PPP001 has the potential to become the long-awaited alternative to opioids for the management of breakthrough pain in cancer patients. Through this trial we are going to gather  more evidence-based data on the safety, efficacy and ease of administration of inhaled cannabinoids as the complementary therapy of choice for cancer related pain.” said Dr. Vigano.

In Canada, the opioid crisis is serious and growing, and imposes devastating effects on families and communities. From January to September 2017, there were at least 2,923 apparent opioid-related deaths of which 92% were accidental. While males make up 76% of these fatalities, the highest percentage (28%) occurred among individuals between the ages of 30 and 39 years.i From January to September 2017, 72% of accidental apparent opioid-related deaths involved fentanyl or fentanyl analogues compared to 55% in 2016.

“Our rich cannabinoid-derived product pipeline has the potential to play a major role in opioid sparing, thus addressing a societal issue of critical proportion,“ said Guy Chamberland, Interim CEO and Chief of Scientific Affairs at Tetra Bio-Pharma.  In addition, the R&D team is in discussions with Health Canada to take PPP001 into other therapeutic indications including fibromyalgia. In taking on new therapeutic indications for PPP001 we can, if successful, significantly increase the potential market as well shareholder value,” said Mr. Chamberland.

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

About Santé Cannabis
Established in Montreal, Quebec in 2014, Santé Cannabis is a Centre of Excellence in medical cannabis research, clinical practice and healthcare professional training. Since its inception, Santé Cannabis has provided medical assessment, education, monitoring and follow-up to 5000 patients referred by more than 2,000 Quebec physicians. Santé Cannabis operates within the guidelines for the authorization of medical cannabis as set out by the Collège des médecins du Québec.   As an independently credentialed clinical trial research organization, and with unparalleled clinical experience supporting both patients and healthcare professionals, Santé Cannabis has established itself as a global leader in medical cannabis research. Santé Cannabis is currently conducting a Health Canada approved Phase 3 trial for PPP001 for advanced cancer patients suffering from uncontrolled pain and associated symptoms, as well as a Phase 2 trial for PPP005 investigating the use of oral capsules of cannabis oil for the treatment of chronic pain. For more information visit  www.santecannabis.ca

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Investor Relations Contact:
Robert (Bob) Bechard
Executive Vice President, Corporate Development and Licensing
Tetra Bio-Pharma Inc.
514-817-2514

Media Contact:
energi PR
Carol Levine
514-288-8500 ext. 226

Stephanie Engel
416-425-9143 ext. 209

———————————-

i https://www.canada.ca/en/health-canada/services/substance-abuse/prescription-drug-abuse/opioids/apparent-opioid-related-deaths.html

betterU $BTRU.ca Expands offering and creates a building-industry category for the India market with industry courses provided by Australia’s Pointsbuild $ARCL $BPI $FC.ca

Posted by AGORACOM-JC at 10:00 AM on Monday, June 18th, 2018

Betteru large

  • broadened its offering and expanded into a new learning category by partnering with Pointsbuild
    • Australian-based e-Learning company founded in 2007,
    • Pointsbuild offers learning for the building industry, education, training courses, innovation and partnerships.
  • betterU will offer 40 Pointsbuild courses on it’s platform to start with plans to grow to 150 courses.

OTTAWA, June 18, 2018 – betterU Education Corp. (TSX-V:BTRU) (FRANKFURT:5OGA), (the “Corporation” or “betterU”), is pleased to announce it has broadened its offering and expanded into a new learning category by partnering with Pointsbuild. An Australian-based e-Learning company founded in 2007, Pointsbuild offers learning for the building industry, education, training courses, innovation and partnerships. betterU will offer 40 Pointsbuild courses on it’s platform to start with plans to grow to 150 courses. These 40 courses are part of the 700+ new courses available through betterU’s platform as previously announced on May 31, 2018.

The building of a global education platform required to support millions of people across many industries, domains and levels of learning requires many partnerships from around the world. “This partnership is the first of its kind for us and supports our goal of deepening the variety of learning offered on our platform,” say Pankaj Raina, Country Head, Australia and New Zealand.

betterU will continue to expand their learning partner acquisition teams around the world to broaden their courses and offering with offices in India, Canada, Switzerland and Australia.

About betterU

betterU, a global education marketplace, aims to provide access to quality education from around the world to foster growth and opportunity to those who want to better their lives. The company’s vision is to help foster the equalization of education for all by bridging the prevailing gap in the education and job industry and enhance the lives of its learners by developing an integrated education-to-employment ecosystem. betterU’s offerings can be categorized into several broad functions: to compliment school programs with flexible KG-12 programs preparing children for next stage of education, to provide access to global educational opportunities from leading educators, to foster an exceptional educational environment by providing befitting skills that lead to a better career, to bridge the gap between one’s existing education and prospective job requirement by training them and lastly, to connect the end user to various job opportunities.

www.betterU.in

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements in this release are forward-looking statements, which include completion of the proposed Investment, the anticipated use of the proceeds of the Investment, the development and expansion of betterU’s operations, and other matters. There can be no assurance that the Investment will be completed as proposed or at all. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as “may”, “expect”, “estimate”, “anticipate”, “intend”, “believe” and “continue” or the negative thereof or similar variations. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, which contribute to the possibility that the predictions, estimates, forecasts, projections and other forward-looking statements will not occur. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, the development of competitive technologies, the marketplace acceptance of betterU’s products, and other factors, many of which are beyond the control of betterU. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release. Except as required by law, betterU disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Additionally, betterU undertakes no obligation to comment on the expectations of, or statements made by, third parties in respect of the matters discussed above. Further information on betterU’s public filings, including their most recent audited consolidated financial statements, are available at www.sedar.com

For further information, please visit https://ir.betteru.ca/investor-overview/press-releases/

better Education Corp.
Brad Loiselle, CEO
On behalf of the Board of Directors

For further information:
Investor Relations
1-613-695-4100 Ext. 233
Email: [email protected]

Namaste $N.ca $NXTTF closes acquisition of 10% share equity of Israeli-based cannabis producer Cannbit Ltd $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:54 AM on Monday, June 18th, 2018

Namaste large new

  • Further to its January 18th, 2018 letter of intent, that the Company has signed a subscription agreement to acquire 10% of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd

VANCOUVER, June 18, 2018 - Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to its January 18th, 2018 letter of intent (“LOI”), that the Company has signed a subscription agreement (the “Agreement”) to acquire 10% of the issued share capital of Israeli licensed producer of medical cannabis, Cannbit Ltd (“Cannbit”) for NIS 2,500,000 or approximately CAD $908,000, which includes a combination of both cash and shares.

Subsequently, Cannbit has also signed a binding agreement to complete a merger with a company listed on the Tel Aviv stock exchange, whereby Cannbit will retain 85% ownership of the combined public entity, The Company believes that its investment will be immediately accretive in nature based on the valuation metrics of the transaction which consequently valued Cannbit significantly higher than what Namaste acquired its 10% equity stake for. In anticipation of closing this transaction, Namaste has established a supply arrangement with Cannbit to export cannabis to the Canadian market (subject to approval by Health Canada and the Israeli government), and will also engage with Cannbit to expand the Company’s Israeli-based vaporizer sales platform.

Namaste remains focused on establishing domestic and international supply arrangements and investments that will secure supply channels of high-quality medical cannabis for the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”). This transaction validates our strategy of sourcing quality cannabis products abroad and introducing them to the Canadian market. Early signs indicate that international cannabis producers are eager to penetrate the Canadian market, and view Namaste as a valuable resource in expanding their market share on an international level. In a relatively short period of time, Namaste has managed to solidify its position as an innovator in e-commerce technology and will leverage its multiple supply arrangements to offer Canadian patients a more diverse offering of cannabis products while remaining focused on its overall vision creating a better user experience.

Management Commentary

Yaron Razon, co-founder and CEO of Cannbit comments: – “We are very pleased to have Namaste join as an investor in Cannbit. Namaste is a global leader in cannabis technology and their investment in Cannbit reinforces their confidence in our management team. We intend to work closely with Namaste to promote joint business activities in Israel and in Canada including the development of unique products and technologies.”

Sean Dollinger, President and CEO of Namaste comments: – “We are once again excited to be closing on another strategic business arrangement that is helping Namaste bring international awareness to its platform. We feel extremely excited to not only be working with a licensed Israeli producer but to be making a strategic long-term investment for the company and our shareholders. As a pioneer of cannabis research and development, we believe Israel will play an important role in the overall cannabis market and this transaction puts the Company in a great position moving forward. We feel very optimistic about the rate at which we have been able to close on many key initiatives and fully expect to continue accelerating our efforts to expand our product offering through our platform. We believe our platform offers many advantages over traditional e-commerce sites as we continue to build a revolutionary platform. As our world-class team continues to expand we fully expect to see more international relationships formed in our quest to offer our customers a truly unique.”

About Cannbit Ltd.
Cannbit is focused on growing high-quality medical-grade cannabis with advanced technology and agriculture platform while utilizing the best human resources to produce the highest level of quality available that will effectively treat a wide range of illnesses. The Israeli government is expected to approve the export of medical cannabis and Cannbit intends to become Israel’s leading exporter for medical cannabis to legal jurisdictions around the globe. Cannbit’s facility is 4,000 square meters with an additional 10,000 square meters available for expansion and is located in Neot Hakikar, an area well known in the Israeli agricultural community with clear advantages in the cold seasons. Our cultivation is carried out in a sophisticated greenhouse that provides ideal conditions for a variety of cannabis strains. Cannbit’s management is comprised of a group of industry professionals in relevant disciplines.

About Namaste Technologies Inc.
Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer pending receipt of a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

New Age Metals $NAM.ca /Azincourt $AAZ.ca Energy Begin $600,000 Field Exploration Program on Lithium Two Project, in South East Manitoba, Winnipeg River Pegmatite Field $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 9:58 AM on Thursday, June 14th, 2018

New age large

-The New Age Metal/Azincourt Option – Joint Venture is the largest claim holder of Lithium Projects in the Winnipeg River Pegmatite Field with over 14,000 hectares (34,800 acres). The Option/Joint Venture has eight projects in this large pegmatite field and are exploring for lithium-bearing pegmatites and Rare Metals.

– Field exploration is underway which includes further ground proofing to better outline drill targets on the Lithium Two Project. Past historical drilling has outlined the Eagle Pegmatite (one of several pegmatites on the project). In 1947 a previous operator reported, 545,000 tonnes of 1.4% Li2O drilled to 60 meters and which was reported as open along strike and to depth. The Eagle Pegmatite is not 43-101 compliant.

– Management feels based on the geological history of the Lithium Two Project, and more specifically the Eagle Pegmatite target, that it is drill ready but management also believes a more in depth field review and geological mapping and sampling program on this large pegmatite would help our technical team to better understand how to pinpoint the summer 2018 drill holes.

– The overall objective for the Lithium Two project is to complete a compliant NI 43-101 report by the end of Q1 2019.

– Field surface exploration will commence on the Lithman West Project as soon as the field team completes the work on Lithium Two. Lithium Two is one of the 3 the drill ready projects and is slated to be drilled later in the year.

– NAM’s Lithium Division has a minimum commitment of $600,000 for exploration and drilling in 2018 which is financed by NAM’s option/joint-venture partner Azincourt Energy Corp. (TSX.V:AAZ).

– NAM’s PGM Division: NAM’s flagship project is its 100% owned River Valley PGM Project (NAM Website – River Valley Project) in the Sudbury Mining District of Northern Ontario (100 km east of Sudbury, Ontario). Presently the River Valley Project is North America’s largest undeveloped primary PGM Project.

June 14th, 2018 / Rockport, Canada – New Age Metals Inc. (TSX.V: NAM; OTCQB: NMTLF; FSE: P7J.F) is pleased to announce that through its Lithium Division, Lithium Canada Developments (LCD) and joint venture partner, Azincourt Energy, that field exploration is proceeding and underway on the Lithium Two Project in southeast Manitoba.

The field crews have nearly completed the first phase of the 2018 surface field exploration on the Lithium Two Project (see figure 1). This project is situated in the active Cat Lake region of southeast Manitoba. The project contains several known lithium-bearing pegmatites (Figure 2) with the Eagle Pegmatite being the largest known to date.

Historical drilling (43-101 non-compliant) of the Eagle Pegmatite in 1947 reported, 545,000 tonnes of 1.4% Li2O drilled to 60 meters and opened along strike and to depth. Management feels based on the geological history of the project that it is drill ready but also felt a field review and geological mapping programs and on this large pegmatite would better help our technical team define the existing summer drill targets.

Given the fact The Eagle Pegmatite is traceable on surface up to approximately 1100 meters and up to 12 meters wide. NAM completed a detailed exploration program of the surface pegmatites in 2016 which returned assays up to 3.04% for LiO2 for the Eagle Pegmatite and 2.08% from the FD5 Pegmatite. The 2018 field program consisted of sampling, prospecting and mapping. Assays will be sent out after the completion of field work on the project. Surface exploration will continue onto other Lithium Projects in the joint venture. Drilling is slated for summer 2018.

All eight Lithium Projects in the option/joint venture are located in the Winnipeg River-Cat Lake Pegmatite Field. This field hosts the world-class Tanco Pegmatite that has been mined for Tantalum, Cesium and Spodumene (one of the primary Lithium ore minerals) in varying capacities, since 1969 at the Tanco Mine. The Tanco Pegmatite is a highly fractionated Lithium-Cesium-Tantalum (LCT Type) pegmatite and numerous other Lithium-bearing pegmatites exist in the Pegmatite Field. The LCT-type pegmatites can contain large amounts of Spodumene (one of the primary ores used in hard rock Lithium extraction) and are a primary geological target in hard rock Lithium exploration. They also can contain economic qualities of Tantalum and Cesium as well as other Lithium bearing minerals such as Mica.

 


Click Image To View Full Size

Figure 1: Lithium Canada Development Southeast Manitoba Project Claim Outline: The Option/Joint Venture is the largest claim holder of Lithium Projects in the Winnipeg River Pegmatite Field with over 14,000 hectares (34,800 acres). Many of the projects have excellent infrastructure and a good ease of access.


Click Image To View Full Size

Figure 2: Geology Map of the Lithium Two Project

OPT-IN LIST

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news or click here.

ABOUT NAM’S PGM DIVISION

NAM’s flagship project is its 100% owned River Valley PGM Project (NAM Website – River Valley Project) in the Sudbury Mining District of Northern Ontario (100 km east of Sudbury, Ontario). Presently the River Valley Project is North America’s largest undeveloped primary PGM deposit with Measured + Indicated resources of 160 million tones @ 0.44 g/t Palladium, 0.17 g/t Platinum, 0.03 g/t Gold, with a total metal grade of 0.64 g/t at a cut-off grade of 0.4 g/t equating to 3,297,173 ounces PGM plus Gold and 4,626,250 PdEq Ounces (Table 1). This equates to 4,626,250 PdEq ounces M+I and 2,713,933 PdEq ounces in inferred (see May 8th, 2018 press release). Having completed a 2018 NI-43-101 resource update the company is finalizing its 2018 exploration programs which will include geophysics, and extensive drill programs, which are all working towards the completion of a Preliminary Economic Assessment (PEA). Our objective is to develop a series of open pits (bulk mining) over the 16 kilometers of mineralization, concentrate on site, and ship the concentrates to the long-established Sudbury Metallurgical Complex. On May 23rd, 2018, NAM’s board approved a Preliminary Economic Assessment (PEA) on River Valley Platinum Group Metals Project’s. Management is currently finalizing its selection of a 3rd party engineering company to complete this PEA. This will be the first economic study on the project. Alaska: April 4th, 2018, NAM signed an agreement with one of Alaska’s top geological consulting companies. The companies stated objective is to acquire additional PGM and Rare Metal projects in Alaska. On April 18th, 2018, NAM announced the right to purchase 100% of the Genesis PGM Project, NAM’s first Alaskan PGM acquisition related to the April 4th agreement. The Genesis PGM Project is a road accessible, under explored, highly prospective, multi-prospect drill ready Pd-Pt-Ni-Cu property.

The results of the new resource estimation are tabulated in Table 1 below (0.4 PdEq cut-off).

Class Tonnes

‘,000

Pd (g/t) Pt (g/t) Rh (g/t) Au (g/t) Cu (%) Ni (%) Co (%) PdEq (g/t)
Total Measured 62,877.5 0.49 0.19 0.02 0.03 0.05 0.01 0.002 0.99
Total Indicated 97,855.2 0.40 0.16 0.02 0.03 0.05 0.01 0.002 0.83
Total Meas +Ind 160,732.7 0.44 0.17 0.02 0.03 0.05 0.01 0.002 0.90
Inferred 127,662.0 0.27 0.12 0.01 0.02 0.05 0.02 0.002 0.66
Class PGM + Au (oz) PdEq (oz) PtEq (oz) AuEq (oz)
Total Measured 1,440,248 1,999,575 1,999,575 1,136,930
Total Indicated 1,856,925 2,626,675 2,626,675 1,463,793
Total Meas +Ind 3,297,173 4,626,250 4,626,250 2,600,724
Inferred 1,578,367 2,713,933 2,713,933 1,323,809

Notes:

1. CIM definition standards were followed for the resource estimation.

2. The 2018 resource models used Ordinary Krig grade estimation within a three-dimensional block model with mineralized zones defined by wireframed solids.

3. A base cut-off grade of 0.4 % g/t PdEq was used for reporting resources.

4. Palladium Equivalent (PdEq) calculated using (US$): $1,000/oz Pd, $1,000/oz Pt, $1,350/oz Au, $1750/oz Rh, $3.20/lb Cu, $5.50/lb Ni, $36/lb Co.

5. Numbers may not add exactly due to rounding.

6. Mineral Resources that are not mineral reserves do not have economic viability

7. The quantity and grade of reported inferred resources in this estimation are uncertain in nature and there has been insufficient exploration to define these inferred resources as an indicated or measured mineral resource and it is uncertain if further exploration will result in upgrading them to an indicated or measured mineral resource category.

ABOUT NAM’S LITHIUM DIVISION

The summer exploration plan has begun for the company’s Lithium Division. NAM has 100% ownership of eight pegmatite hosted Lithium Projects in the Winnipeg River Pegmatite Field, located in SE Manitoba, with focus on Lithium bearing pegmatites. Three of the projects are drill ready. This Pegmatite Field hosts the world class Tanco Pegmatite that has been mined for Tantalum, Cesium and Spodumene (one of the primary Lithium ore minerals) in varying capacities, since 1969. NAM’s Lithium Projects are strategically situated in this prolific Pegmatite Field. Presently, NAM is the largest mineral claim holder for Lithium and Rare Metal projects in the Winnipeg River Pegmatite Field.

Lithium Canada Development is a 100% owned subsidiary of New Age Metals (NAM) who presently has an agreement with Azincourt Energy Corporation (AAZ) whereby AAZ will now commit on its first year a minimum of $600,000 in 2018. In its initial earn in AAZ may earn up to 50%, of the eight Lithium projects that are 100% owned by NAM. AAZ’s 50% exploration expenditure earn in is approximately $2.850 million and should they continue with their option they must issue up to 1.75 million shares of AAZ to NAM. NAM has a 2% royalty on each of eight Lithium Projects in this large pegmatite field. For additional information on the NAM/AAZ option/joint-venture and recent acquisitions (see the news releases dated Jan 15, 2018, May 2, 2018, May 10, 2018).

QUALIFIED PERSON

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Carey Galeschuk, a consulting geoscientist for New Age Metals. Mr. Galeschuk is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

ADDITIONAL INFORMATION

Should you have additional inquiries, please contact Paul Poggione, Corporate Development, Tel: 1-613-659-2773, email: [email protected].

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.